KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Payables (2016 - 2025)

Historic Payables for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $169.6 million.

  • Charles River Laboratories International's Payables rose 2475.09% to $169.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.6 million, marking a year-over-year increase of 2475.09%. This contributed to the annual value of $140.3 million for FY2024, which is 1692.94% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Payables stood at $169.6 million, which was up 2475.09% from $145.8 million recorded in Q2 2025.
  • Charles River Laboratories International's Payables' 5-year high stood at $226.0 million during Q1 2022, with a 5-year trough of $110.9 million in Q2 2021.
  • Moreover, its 5-year median value for Payables was $140.3 million (2024), whereas its average is $155.7 million.
  • Its Payables has fluctuated over the past 5 years, first surged by 9056.04% in 2022, then tumbled by 4689.55% in 2023.
  • Over the past 5 years, Charles River Laboratories International's Payables (Quarter) stood at $198.1 million in 2021, then increased by 3.93% to $205.9 million in 2022, then dropped by 17.96% to $168.9 million in 2023, then dropped by 16.93% to $140.3 million in 2024, then rose by 20.86% to $169.6 million in 2025.
  • Its Payables was $169.6 million in Q3 2025, compared to $145.8 million in Q2 2025 and $149.3 million in Q1 2025.